Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Cancers
|
February 15, 2022
Radiomic Phenotypes for Improving Early Prediction of Survival in Stage III Non-Small Cell Lung Cancer Adenocarcinoma after Chemoradiation
José Marcio Luna, Andrew R Barsky, Russell T Shinohara, et al.
Advances in Radiation Oncology
|
November 24, 2022
Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?
Christopher M Wright, Alexandra D Dreyfuss, Jonathan A Baron, et al.
Cancer Medicine
|
January 21, 2021
The efficacy and safety of definitive concurrent chemoradiotherapy for non-operable esophageal cancer
Alexandra D Dreyfuss, Andrew R Barsky, E Paul Wileyto, et al.
Clinical Lung Cancer
|
July 3, 2020
Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma
Andrew R Barsky, Christopher A Ahern, Sriram Venigalla, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|
November 24, 2023
Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer
Andrew R Barsky, Jerry George, Andrew J Wroe, et al.
Cureus
|
October 14, 2020
Initial Clinical Experience Treating Patients With Lung Cancer on a 6MV-Flattening-Filter-Free O-Ring Linear Accelerator
Andrew R Barsky, Hui Lin, Amberly Mendes, et al.
Oral Oncology
|
September 2, 2021
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery
Christopher M Wright, Daniel Y Lee, David Shimunov, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 25, 2020
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
Christopher M Wright, Michael J LaRiviere, Jonathan A Baron, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Cancers
|
February 15, 2022
Radiomic Phenotypes for Improving Early Prediction of Survival in Stage III Non-Small Cell Lung Cancer Adenocarcinoma after Chemoradiation
José Marcio Luna, Andrew R Barsky, Russell T Shinohara, et al.
Advances in Radiation Oncology
|
November 24, 2022
Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?
Christopher M Wright, Alexandra D Dreyfuss, Jonathan A Baron, et al.
Cancer Medicine
|
January 21, 2021
The efficacy and safety of definitive concurrent chemoradiotherapy for non-operable esophageal cancer
Alexandra D Dreyfuss, Andrew R Barsky, E Paul Wileyto, et al.
Clinical Lung Cancer
|
July 3, 2020
Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma
Andrew R Barsky, Christopher A Ahern, Sriram Venigalla, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|
November 24, 2023
Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer
Andrew R Barsky, Jerry George, Andrew J Wroe, et al.
Cureus
|
October 14, 2020
Initial Clinical Experience Treating Patients With Lung Cancer on a 6MV-Flattening-Filter-Free O-Ring Linear Accelerator
Andrew R Barsky, Hui Lin, Amberly Mendes, et al.
Oral Oncology
|
September 2, 2021
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery
Christopher M Wright, Daniel Y Lee, David Shimunov, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 25, 2020
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
Christopher M Wright, Michael J LaRiviere, Jonathan A Baron, et al.
Page
of 4